Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition has created new challenges in the industry. To address these challenges and boost productivity, QPS has teamed up with SCIEX, a global leader in life science analytical technologies, to advance a …